WNT1 and breast cancer: To further characterize the inhibitory effect of the Mesd C-terminal region peptide in prostate and breast cancer cells, we transiently transfected PC-3 and HS578T cells with Wnt1 and Wnt reporter plasmids and treated with Mesd protein or human Mesd peptide hMesd (160–197).